The cholesterol-complexing agent digitonin modulates ligand binding of the bovine hippocampal serotonin<SUB>1A</SUB> receptor by Paila, Yamuna Devi et al.
The cholesterol-complexing agent digitonin modulates ligand binding
of the bovine hippocampal serotonin1A receptor
YAMUNA DEVI PAILA, THOMAS J. PUCADYIL, & AMITABHA CHATTOPADHYAY
Centre for Cellular and Molecular Biology, Hyderabad, India
(Received 22 November 2004: revised 3 February 2005)
Abstract
The serotonin1A (5-HT1A) receptor is an important member of the superfamily of seven transmembrane domain G-protein-
coupled receptors. We have examined the modulatory role of cholesterol on the ligand binding of the bovine hippocampal 5-
HT1A receptor by cholesterol complexation in native membranes using digitonin. Complexation of cholesterol from bovine
hippocampal membranes using digitonin results in a concentration-dependent reduction in specific binding of the agonist 8-
OH-DPAT and antagonist p -MPPF to 5-HT1A receptors. The corresponding changes in membrane order were monitored
by analysis of fluorescence polarization data of the membrane depth-specific probes, DPH and TMA-DPH. Taken together,
our results point out the important role of membrane cholesterol in maintaining the function of the 5-HT1A receptor. An
important aspect of these results is that non-availability of free cholesterol in the membrane due to complexation with
digitonin rather than physical depletion is sufficient to significantly reduce the 5-HT1A receptor function. These results
provide a comprehensive understanding of the effects of the sterol-complexing agent digitonin in particular, and the role of
membrane cholesterol in general, on the 5-HT1A receptor function.
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Abbreviations: BCA, bicinchoninic acid, DMPC, dimyristoyl-sn-glycero-3-phosphocholine, DPH, 1,6-diphenyl-
1,3,5-hexatriene, 5-HT, 5-hydroxytryptamine, 8-OH-DPAT, 8-hydroxy-2(di-N-propylamino)tetralin, p-MPPF, 4-(2?-
methoxy)-phenyl-1-[2?-(N-2ƒ-pyridinyl)-p-fluorobenzamido]ethyl-piperazine, p-MPPI, 4-(2?-methoxy)-phenyl-1-[2?-(N-
2ƒ-pyridinyl)-p-iodobenzamido]ethyl-piperazine, PMSF, phenylmethylsulfonyl fluoride, TMA-DPH, 1-[4-(trimethyl-
ammonio)phenyl]-6-phenyl-1,3,5-hexatriene, TLC, thin layer chromatography, Tris, tris-(hydroxymethyl)aminomethane.
Introduction
G-protein-coupled receptors constitute a superfam-
ily of transmembrane proteins whose function is to
transmit information across the cell membrane from
the extracellular environment to the interior of the
cells, thus providing a mechanism of communication
between the exterior and the interior of the cell [1,2].
They represent major targets for the development of
novel drug candidates in all clinical areas [3,4]. It is
estimated that 50% of clinically prescribed drugs act
as either agonists or antagonists of G-protein-
coupled receptors which points to their immense
therapeutic potential [5]. The membrane organiza-
tion of G-protein-coupled receptors assumes signifi-
cance in the light of their role in health and disease.
Interestingly, the efficiency of signal transduction
processes carried out by G-protein-coupled recep-
tors appears to be influenced by the local composi-
tion and organization of lipids within the plasma
membrane [6]. It has been proposed that the
G-protein-coupled receptors are not uniformly pre-
sent on the plasma membrane but are concentrated
in specific membrane microdomains [7,8]. It has
been shown that some of these domains are enriched
in cholesterol [6]. For example, it has recently been
reported that serotonin2A receptors are localized
in cholesterol-enriched membrane microdomains
(caveolae) and serotonergic signaling induced by
serotonin2A receptors depends on the membrane
cholesterol content [9] and on caveolin-1, a scaffold-
ing protein found in caveolae [10]. Localization of
G-protein-coupled receptors into domains has given
rise to new challenges and complexities in receptor
signaling since signaling has to be understood in
context of the three dimensional organization of
various signal transduction components which in-
clude receptors and G-proteins [7].
Cholesterol is an essential component of eukar-
yotic membranes and plays a crucial role in mem-
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brane organization, dynamics, function, and sorting
[11,12]. It is often found distributed non-randomly
in domains or pools in biological and model mem-
branes [13/15]. Many of these domains are believed
to be important for the maintenance of membrane
structure and function. Cholesterol in the plasma
membrane plays a key role in regulating the activity
of membrane proteins including receptors [reviewed
in ref. 16]. The interaction between cholesterol and
other membrane components (such as receptors) in
the brain therefore assumes relevance for a compre-
hensive understanding of brain function.
Serotonin receptors represent one of the largest,
evolutionarily ancient, and highly conserved families
of G-protein-coupled receptors [17]. Serotonin ex-
erts its diverse actions by binding to distinct cell
surface receptors which have been classified into
many groups [18]. Serotonin receptors are members
of a superfamily of seven transmembrane domain
receptors [1,2] that couple to and transduce signals
via GTP-binding regulatory proteins (G-proteins)
[19]. Among the 14 subtypes of serotonin receptors,
the G-protein coupled 5-HT1A receptor is the best
characterized for a variety of reasons [20]. We have
earlier partially purified and solubilized 5-HT1A
receptors from bovine hippocampus in a functionally
active form [21,22].
We have recently shown the requirement of
membrane cholesterol in modulating ligand binding
activity of the 5-HT1A receptor from the bovine
hippocampus [23]. This was achieved by the use of
methyl-b-cyclodextrin which physically depletes
cholesterol from membranes. Treatment of bovine
hippocampal membranes with methyl-b-cyclodex-
trin therefore resulted in specific removal of mem-
brane cholesterol without any change in
phospholipid content. Removal of cholesterol from
bovine hippocampal membranes in this manner
resulted in a reduction in ligand binding and G-
protein coupling to the 5-HT1A receptor [23]. If
cholesterol is necessary for ligand binding of the 5-
HT1A receptor, modulating cholesterol availability
by other means could lead to similar effects on the 5-
HT1A receptor function. In this paper, we have
tested this proposal by treating the membranes with
the sterol-complexing agent digitonin which does
not physically deplete membrane cholesterol, yet
would effectively reduce cholesterol-receptor inter-
actions in the membrane due to complexation
[24,25]. Digitonin is a plant glycoalkaloid saponin
detergent (see Figure 1) obtained from Digitalis
purpurea . It forms water-insoluble 1:1 complexes
(termed ‘digitonides’) with cholesterol and other
steroids, which possess a planar sterol nucleus, a
3b-hydroxy-D5 configuration and a hydrophobic side
chain at C17 [26]. Digitonin treatment has been
shown to result in the formation of cholesterol-
digitonin rich domains in the membrane [27], thus
reducing the freely available cholesterol capable of
interacting with other membrane constituents such
as receptors. This property of digitonin has resulted
in its use as an agent to distinguish between
cholesterol-rich and -poor membranes in the ultra-
structure analysis of cell membranes [28].
In this paper, we have monitored the modulatory
role of cholesterol on the function (specific agonist
and antagonist binding) of the bovine hippocampal
5-HT1A receptor by cholesterol complexation in
native membranes using digitonin. The correspond-
ing changes in membrane dynamics were monitored
by analysis of fluorescence polarization data of the
membrane depth-specific probes, DPH and TMA-
DPH.
Materials and methods
Materials
BCA, DMPC, DPH, EDTA, EGTA, MgCl2,
MnCl2, Na2HPO4, p-MPPI, PMSF, TMA-DPH,
Tris, iodoacetamide, polyethylenimine, serotonin,
sodium azide, and sucrose were obtained from
Sigma Chemical Co. (St. Louis, MO). Digitonin
was from Research Organics (Cleveland, OH).
Amplex Red cholesterol assay kit was from
Molecular Probes (Eugene, OR). [3H]8-OH-
DPAT (specific activity/135.0 Ci/mmol) and
[3H]p-MPPF (specific activity/70.5 Ci/mmol)
were purchased from DuPont New England Nuclear
(Boston, MA). BCA reagent kit for protein estima-
tion was obtained from Pierce (Rockford, IL). All
other chemicals used were of the highest available
quality. GF/B glass microfiber filters were from
Whatman International (Kent, UK). Pre-coated
silica gel 60 thin layer chromatography plates were
from Merck (Merck KGaA, Germany). All solvents
used were of analytical grade. Water was purified
through a Millipore (Bedford, MA) Milli-Q system
and used throughout. Fresh bovine brains were
obtained from a local slaughterhouse within 10 min
of death and the hippocampal region was carefully
dissected out. The hippocampi were immediately
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Figure 1. Chemical structure of digitonin.
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flash frozen in liquid nitrogen and stored at /708C
till further use.
Preparation of native hippocampal membranes
Native hippocampal membranes were prepared as
described earlier [23]. Protein concentration was
determined using the BCA reagent with bovine
serum albumin as a standard [29].
Preparation of digitonin stock solutions and treatment of
hippocampal membranes
Stock solutions of digitonin in water were prepared
as described previously [30]. Briefly, digitonin was
dissolved in ethanol by mild shaking in a water bath
at 378C and the solution was evaporated to dryness
under a gentle stream of N2. This procedure results
in the deposition of a fine film of digitonin on the
walls of the glass tube that dissolves instantly upon
addition of water. Aliquots of this aqueous stock
solution were immediately added to hippocampal
membranes at a total protein concentration of
0.5 mg/ml in 50 mM Tris, pH 7.4 buffer and
incubated for 1 h at 258C with constant shaking.
Membrane solubilization mediated by digitonin
was assayed as described previously [31]. Briefly,
membrane samples treated with increasing concen-
trations of digitonin for 1 h at 258C were spun down
at 100,000/g for 45 min at 48C. The lipid phos-
phate and cholesterol content of the membrane
pellet dissolved in 50 mM Tris, pH 7.4 buffer was
assayed as described below.
Estimation of inorganic phosphate and cholesterol
The concentration of lipid phosphate was deter-
mined subsequent to total digestion by perchloric
acid [32] using Na2HPO4 as standard. DMPC was
used as an internal standard to assess lipid digestion.
Samples without perchloric acid digestion produced
negligible readings. Membrane cholesterol was
estimated using the Amplex Red cholesterol assay
kit [33].
Thin layer chromatography of lipids extracted from
native membranes
Lipid extraction was carried out according to Bligh
and Dyer [34]. The extracts were dried under a
stream of nitrogen at 458C. The dried extracts were
resuspended in a mixture of chloroform/methanol
(1:1, v/v). Thin layer chromatography of the ex-
tracted lipids was carried out using chloroform/
methanol/water (65:25:4, v/v/v). The separated li-
pids were visualized by charring with a solution
containing cupric sulfate (10% w/v) and phosphoric
acid (8% v/v) at 1508C. The TLC plates were
scanned and lipids band intensities were analyzed
using the Adobe Photoshop software version 5.0
(Adobe Systems Inc., San Jose, CA).
Radioligand binding assays
Receptor binding assays were carried out as de-
scribed earlier [35,36] in presence of increasing
concentrations of digitonin using 0.5 mg total
protein.
Fluorescence polarization measurements
Fluorescence polarization experiments were carried
out with membranes containing 50 nmol of
total phospholipids suspended in 1.5 ml of 50 mM
Tris, pH 7.4 buffer with increasing concentrations
of digitonin as described earlier [23,31]. Stock
solutions of the fluorescent probes (DPH and
TMA-DPH) were prepared in methanol. The
amount of probe added was such that the final
probe concentration was 1 mol% with respect to the
total phospholipid content. This ensures optimal
fluorescence intensity with negligible membrane
perturbation. Membranes were vortexed for
1 min after addition of the probe and kept in the
dark for 1 h before measurements. Background
samples were prepared the same way except that
the probe was omitted. The final probe concentra-
tion was 0.33 mM in all cases and the methanol
content was low (0.03% v/v). Control experiments
showed that at this concentration of methanol,
the ligand binding properties of the receptor are
not altered.
Steady state fluorescence was measured in a
Hitachi F-4010 spectrofluorometer using 1 cm
path length quartz cuvettes at room temperature
(238C). Excitation and emission wavelengths were
set at 358 and 430 nm. Excitation and emission slits
with nominal bandpasses of 1.5 nm and 20 nm were
used. The excitation slit was kept low to avoid any
photoisomerization of DPH and TMA-DPH. In
addition, fluorescence was measured with a 30 sec
interval between successive openings of the excita-
tion shutter (when the sample was in the dark in the
fluorimeter) to reverse any photoisomerization of
DPH and TMA-DPH [37]. Fluorescence polariza-
tion experiments were performed using a Hitachi
polarization accessory. Polarization values were cal-
culated from the equation [38]:
P(IVVGIVH)=(IVVGIVH) (1)
where IVV and IVH are the measured fluorescence
intensities (after appropriate background subtrac-
tion) with the excitation polarizer vertically oriented
and the emission polarizer vertically and horizontally
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oriented, respectively. G is the instrumental correc-
tion factor and is the ratio of the efficiencies of the
detection system for vertically and horizontally
polarized light and is equal to IHV/IHH. The optical
density (measured with a Hitachi U-2000 spectro-
photometer using 1 cm path length quartz cuvettes)
of the membrane samples in the absence of digitonin
measured at 358 nm was /0.2 which increased in
presence of digitonin. To avoid any scattering
artifacts due to the presence of digitonin, the
fluorescence polarization values reported in Figure
7 were corrected for scattering by diluting
the samples with 50 mM Tris, pH 7.4 buffer as
described earlier [39]. Fluorescence polarization
values of samples (control and digitonin-treated,
undiluted and diluted with the same buffer)
were plotted against their corresponding optical
densities as shown in Figure 6. The intercept on
the ordinate (y-axis) from linear fits of this data was
considered as the corrected fluorescence polarization
value.
Results
Digitonin complexes membrane cholesterol without
altering the cholesterol and phospholipid contents of
hippocampal membranes
Digitonin is a widely used detergent and has been
used to solubilize specific membrane components
such as receptors [40]. It is therefore important to
choose a range of concentration where digitonin
would be present predominantly as a monomer and
exert its cholesterol-complexing activity without
causing any significant loss of membrane lipids
(cholesterol and/or phospholipids). We estimated
the loss of membrane lipids in the presence of
digitonin by assaying the amount of total cholesterol
and phospholipids present in the insoluble pellet
obtained by high speed centrifugation following
digitonin treatment [31]. The total cholesterol con-
tent was analyzed by TLC of lipids extracted from
digitonin-treated membranes. Figure 2a shows a thin
layer chromatogram of lipids extracted from native
membranes, and membranes treated with 0.6 and
1 mM digitonin. Quantitative densitometric analysis
of the cholesterol content on the TLC plate (Figure
2b) indicates that the treatment with digitonin does
not deplete membrane cholesterol. However, analy-
sis of the cholesterol content of digitonin-treated
membranes using the cholesterol oxidase enzyme
based Amplex Red cholesterol assay kit [33] reveals
a reduction in the free (available) cholesterol content
(Figure 2b). Thus, treatment of membranes
with 1 mM digitonin reduces the available choles-
terol content by /50%. These results suggest
that the presence of digitonin reduces the ability
of the enzyme cholesterol oxidase to catalyze the
oxidation of cholesterol thereby demonstrating
the cholesterol-complexing ability of digitonin.
Importantly, Figure 3 shows that in the concentra-
tion range of digitonin used (up to 1 mM), there is
minimal loss of phospholipid content. All experi-
ments were therefore carried out with this range (up
to 1 mM) of digitonin concentration that complexes
membrane cholesterol to a significant extent without
physically depleting membrane lipids.
Figure 2. Cholesterol-complexing effect of digitonin. Total lipids
extracted from digitonin-treated membranes were separated by
thin layer chromatography as shown in (a). The lanes represent
lipids extracted from native membranes (lane 2), and membranes
treated with 0.6 mM (lane 3) and 1 mM (lane 4) digitonin. The
arrow represents position of cholesterol on the thin layer
chromatogram identified using a standard in lane 1. The total
and freely available cholesterol content in digitonin-treated
membranes were distinguished as shown in (b). The total
cholesterol content (grey bars) in the lipid extract was determined
by a densitometric analysis of the thin layer chromatogram. Values
are expressed as a percentage of the cholesterol content in native
membranes in the absence of digitonin. The amount of freely
available cholesterol content (white bars) in membranes treated
with digitonin was determined by the Amplex Red cholesterol
assay kit. Values are expressed as a percentage of available
cholesterol in native membranes in the absence of digitonin. Data
represents the mean9/SD of two independent experiments. See
Materials and methods for further details.
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Ligand binding to 5-HT1A receptors is differentially
affected in presence of digitonin
Figure 4 shows the reduction in the specific binding
of the selective 5-HT1A receptor agonist [
3H]8-OH-
DPAT with increasing concentrations of digitonin,
which results in progressive complexation of mem-
brane cholesterol. This shows that complexation of
cholesterol from hippocampal membranes results in
loss of specific agonist binding to the 5-HT1A
receptor. Thus, the specific agonist binding reduces
by 86% in the presence of 1 mM digitonin. To the
best of our knowledge, this result represents the first
observation of reduction in specific ligand binding to
the 5-HT1A receptor due to complexation of mem-
brane cholesterol by digitonin.
Figure 5 shows the decrease in specific binding of
the 5-HT1A selective antagonist [
3H]p-MPPF in the
presence of increasing concentrations of digitonin.
In contrast to the observed reduction in specific
agonist binding (Figure 4), the reduction in specific
antagonist binding appears to be more drastic at
lower digitonin concentrations used. For example,
the reduction in specific antagonist binding is
/83% in the presence of 0.4 mM digitonin. The
corresponding reduction in specific agonist binding
is /42% (see Figure 4). Taken together, these
results show that the complexation of free membrane
cholesterol in hippocampal membranes results in the
loss of the 5-HT1A receptor ligand binding ability.
Although the requirement of membrane cholesterol
for ligand binding to 5-HT1A receptors [23], and
other G-protein-coupled receptors [41] has been
demonstrated earlier, the present results constitute
the first observation where the availability of free
cholesterol rather than its mere physical presence in
the membrane is essential for receptor function.
Change in hippocampal membrane dynamics due to
digitonin treatment
The overall membrane order and dynamics could be
an important determinant for the function of a
transmembrane receptor, a large portion of which
remains in contact with membrane lipids. In order to
explore the possible changes in membrane order
induced by digitonin treatment, we measured the
fluorescence polarization of membrane depth-speci-
fic fluorescence probes DPH and TMA-DPH. In
general, fluorescence polarization is correlated to the
rotational diffusion [38] of membrane embedded
probes, which is sensitive to the packing of fatty acyl
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Figure 4. Effect of increasing concentrations of digitonin on
specific [3H]8-OH-DPAT binding to the 5-HT1A receptor in
hippocampal membranes. Values are expressed as a percentage of
specific binding for native membranes in the absence of digitonin.
Data shown are the means9/SE of at least three independent
experiments. See Materials and methods for other details.
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Figure 5. Effect of increasing concentrations of digitonin on
specific [3H]p -MPPF binding to the 5-HT1A receptor in hippo-
campal membranes. Values are expressed as a percentage of
specific binding for native membranes in the absence of digitonin.
Data shown are the means9/SE of at least three independent
experiments. See Materials and methods for other details.
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Figure 3. Effect of increasing concentrations of digitonin on the
phospholipid content of bovine hippocampal membranes. Phos-
pholipid contents were assayed as described in Materials and
methods. Values are expressed as a percentage of the phospholipid
content in native membranes in the absence of digitonin. Data
represent the means9/SE of three independent experiments.
Cholesterol and serotonin1A receptor function 245
chains and cholesterol. Since membranes display a
considerable degree of anisotropy in terms of mo-
tional properties of constituent lipids and proteins
[42], a comprehensive understanding of membrane
dynamics can be achieved by the use of more than
one probe which localize at different depths in the
membrane. DPH and its derivatives represent pop-
ular probes for monitoring organization and dy-
namics in membranes [43]. On account of its
hydrophobicity, DPH readily partitions into the
membrane and localizes at the fatty acyl chain region
in the membrane. TMA-DPH is a derivative of DPH
with a cationic moiety attached to the para position
of one of the phenyl rings [44]. The amphipathic
TMA-DPH is oriented in the membrane with its
positive charge localized at the membrane interface
[45]. The DPH moiety in TMA-DPH is localized
at /11 A˚ from the center of the membrane and
reports the interfacial region of the membrane [46].
In contrast, the average location of DPH has
been shown to be /8 A˚ from the center of the
membrane [46].
We observed an increase in the optical density of
samples upon increasing the concentration of digi-
tonin which could complicate fluorescence polariza-
tion measurements using DPH and TMA-DPH.
The fluorescence polarization data obtained under
these conditions were corrected for scattering arti-
facts according to the formalism previously devel-
oped by Lentz et al. [39]. Representative plots (at
0.6 mM digitonin) of experimentally-measured fluo-
rescence polarization as a function of optical density
at the excitation wavelength are shown in Figure 6.
The intercept on the ordinate (y-axis) from linear fits
of this data gives the corrected fluorescence polar-
ization value [39]. The correction significantly
altered the polarization values of samples containing
digitonin while the polarization values of control
samples (without digitonin) remained unaltered.
Corrected fluorescence polarization values of
DPH and TMA-DPH obtained this way as a
function of digitonin concentration are shown in
Figure 7. As apparent from the figure, the corrected
fluorescence polarization of DPH (/0.35) in hip-
pocampal membranes in the absence of digitonin is
lower than that of TMA-DPH (/0.37). The higher
polarization of TMA-DPH compared to DPH is
indicative of the shallower interfacial location of
TMA-DPH in the membrane [23]. The fluores-
cence polarization of both the probes shows an
overall decrease with increasing concentrations of
digitonin. Interestingly, the extent of reduction in
fluorescence polarization is higher for DPH (11%)
compared to TMA-DPH (7%) up to 1 mM digito-
nin used. The presence of digitonin (at concentra-
tions that do not deplete membrane lipids, see
Figures 2 and 3) therefore induces asymmetric
reduction in the membrane order in different regions
of the membrane. Importantly, the relatively modest
alterations in fluorescence polarization values of
DPH and TMA-DPH in hippocampal membranes
treated with digitonin ensure that the overall mor-
phology of the membrane remains intact and rule
out any possibility of gross changes in membrane
architecture.
Discussion
Lipid-protein interactions play a crucial role in
maintaining the structure and function of integral
membrane proteins and receptors [47,48]. Monitor-
ing lipid-receptor interactions is of particular im-
portance because a cell has the ability of varying the
lipid composition of its membrane in response to a
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Figure 6. Representative plots of fluorescence polarization as a function of optical density. The plots represent the fluorescence polarization
of (a) DPH and (b) TMA-DPH for native membranes (k) which serve as control and 0.6 mM digitonin-treated membranes (m) upon
dilution with 50 mM Tris, pH 7.4 buffer. Fluorescence polarization was calculated as described in Materials and methods at 238C. The
solid lines are linear fits to the data with the intercept on the ordinate (y-axis) considered as the corrected fluorescence polarization [39].
The plots are data from at least three independent experiments. See Materials and methods for other details.
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variety of stress and stimuli, thus changing the
environment and the activity of the receptors in its
membrane. In view of the importance of cholesterol
in relation to membrane domains [11,15], the
interaction of cholesterol with membrane receptors
[16] represents an important determinant in func-
tional studies of such receptors, especially in the
nervous system.
We show here that complexation of cholesterol in
hippocampal membranes using digitonin results in a
concentration-dependent reduction in specific ago-
nist and antagonist binding to 5-HT1A receptors.
Complexation of membrane cholesterol with digito-
nin is believed to reduce the availability of free
cholesterol (present data and [26]) essential to
support important membrane functions. This is
supported by the observation that the presence of
digitonin restores the otherwise suppressed phase
transition [49] of dipalmitoylphosphatidylcholine
membranes containing cholesterol [25]. The accom-
panying changes in membrane order were reported
by corresponding changes in fluorescence polariza-
tion of membrane probes, such as DPH and TMA-
DPH, which are localized at different positions
(depths) in the membrane. These results point out
the important role of membrane cholesterol in
maintaining the function of the 5-HT1A receptor.
This result assumes significance in the light of a
tightly bound cholesterol molecule in the recently
reported crystallographic structure of metarhodop-
sin I, an important photointermediate of rhodopsin
which is a representative member of the G-protein-
coupled receptor family [50].
Our results on the inhibition of ligand binding to
5-HT1A receptors in the presence of the cholesterol-
complexing agent digitonin confirm and extend our
previous observation on the requirement of mem-
brane cholesterol for efficient 5-HT1A receptor
function [23]. Importantly, since digitonin does
not physically deplete cholesterol from membranes
unlike agents such as methyl-b-cyclodextrin, our
results serve to delineate the mechanism by which
cholesterol exerts its influence on the 5-HT1A
receptor function. We conclude that the mere non-
availability of free cholesterol in the membrane is
sufficient to significantly reduce the 5-HT1A recep-
tor function. These results provide a comprehensive
understanding of the effects of the sterol-complexing
agent digitonin in particular, and the role of mem-
brane cholesterol in general, on the 5-HT1A receptor
function from a lipid-protein interaction perspective.
Acknowledgements
This work was supported by the Council of Scien-
tific and Industrial Research, Government of India.
A.C. is an honorary faculty member of the Jawahar-
lal Nehru Centre for Advanced Scientific Research,
Bangalore (India). Y.D.P. and T.J.P. thank the
Council of Scientific and Industrial Research for
the award of Junior and Senior Research Fellow-
ships. We thank S. Rajanna, Shanti Kalipatnapu,
Md. Jafurulla and Sandeep Shrivastava for help with
the tissue collection and members of our laboratory
for critically reading the manuscript.
References
[1] Pierce KL, Premont RT, Lefkowitz RJ. Seven-transmem-
brane receptors. Nat Rev Mol Cell Biol 2002;3:639/650.
[2] Cohen-Tannoudji J, Counis R, Herve´ D, Shi DL, Verge´ D. G
protein coupled receptors: new insights into signaling and
regulation. Biol Cell 2004;96:325/326.
[3] Edwards SW, Tan CM, Limbird LE. Localization of G-
protein-coupled receptors in health and disease. Trends
Pharmacol Sci 2000 2003;21:304/308.
[4] Bikker JA, Trumpp-Kallmeyer S, Humblet C. G-protein
coupled receptors: models, mutagenesis, and drug design. J
Med Chem 1998;41:2911/2927.
[5] Karnik SS, Gogonea S, Patil S, Saad Y, Takezako T.
Activation of G-protein-coupled receptors: a common mo-
lecular mechanism. Trends Endocrinol Metab 2003;
14:431/437.
[6] Ostrom RS, Insel PA. The evolving role of lipid rafts and
caveolae in G protein-coupled receptor signaling: implica-
tions for molecular pharmacology. Br J Pharmacol 2004;
143:235/245.
[7] Ostrom RS, Post SR, Insel PA. Stoichiometry and compart-
mentation in G protein-coupled receptor signaling: implica-
tions for therapeutic interventions involving Gs. J Pharmacol
Exp Ther 2000;294:407/412.
Concentration of digitonin (mM)
Co
rre
ct
ed
 fl
uo
re
sc
en
ce
 
po
la
riz
at
io
n
10.80.60.40.20
0.4
0.35
0.3
0.25
Figure 7. Effect of increasing concentrations of digitonin on
fluorescence polarization of membrane probes DPH (k) and
TMA-DPH (m) in hippocampal membranes. Fluorescence
polarization experiments were carried out with membranes
containing 50 nmol phospholipid at a probe to phospholipid ratio
of 1:100 (mol/mol) at room temperature (238C). The data show
corrected fluorescence polarization values (as described in Mate-
rials and methods, and representative plots shown in Figure 6)
and represent the means9/SE of at least three independent
experiments. The solid lines are linear fits of the data. See
Materials and methods for other details.
Cholesterol and serotonin1A receptor function 247
[8] Ostrom RS. New determinants of receptor-effector coupling:
trafficking and compartmentation in membrane microdo-
mains. Mol Pharmacol 2002;61:473/476.
[9] Dreja K, Voldstedlund M, Vinten J, Tranum-Jensen J,
Hellstrand P, Swa¨rd K. Cholesterol depletion distrupts
caveolae and differentially impairs agonist-induced arterial
contraction. Arterioscler Thromb Vasc Biol 2002;22:1267/
1272.
[10] Bhatnagar A, Sheffler DJ, Kroeze WK, Compton-Toth B,
Roth BL. Caveolin-1 interacts with 5-HT2A serotonin
receptors and profoundly modulates the signaling of selected
Gaq-coupled protein receptors. J Biol Chem 2004;279:
34614/34623.
[11] Liscum L, Underwood KW. Intracellular cholesterol trans-
port and compartmentation. J Biol Chem 1995;270:
15443/15446.
[12] Simons K, Ikonen E. How cells handle cholesterol. Science
2000;290:1721/1725.
[13] Schroeder F, Woodford JK, Kavecansky J, Wood WG, Joiner
C. Cholesterol domains in biological membranes. Mol
Membr Biol 1995;12:113/119.
[14] Rukmini R, Rawat SS, Biswas SC, Chattopadhyay A.
Cholesterol organization in membranes at low concentra-
tions: effects of curvature stress and membrane thickness.
Biophys J 2001;81:2122/2134.
[15] Simons K, Ikonen E. Functional rafts in cell membranes.
Nature 1997;387:569/572.
[16] Burger K, Gimpl G, Fahrenholz F. Regulation of receptor
function by cholesterol. Cell Mol Life Sci 2000;57:1577/
1592.
[17] Peroutka SJ, Howell TA. The molecular evolution of G
protein-coupled receptors: focus on 5-hydroxytryptamine
receptors. Neuropharmacology 1994;33:319/324.
[18] Hoyer D, Hannon JP, Martin GR. Molecular, pharmacolo-
gical and functional diversity of 5-HT receptors. Pharmacol
Biochem Behav 2002;71:533/554.
[19] Clapham DE. The G-protein nanomachine. Nature
1996;379:297/299.
[20] Pucadyil TJ, Kalipatnapu S, Chattopadhyay A. The seroto-
nin1A receptor: a representative member of the serotonin
receptor family. Cell Mol Neurobiol 2005;(in press).
[21] Chattopadhyay A, Harikumar KG, Kalipatnapu S. Solubi-
lization of high affinity G-protein-coupled serotonin1A
receptors from bovine hippocampus using pre-miceller
CHAPS at low concentration. Mol Membr Biol 2002;19:
211/220.
[22] Chattopadhyay A, Jafurulla MD, Kalipatnapu S, Pucadyil
TJ, Harikumar KG. Role of cholesterol in ligand binding
and G-protein coupling of serotonin1A receptors solubilized
from bovine hippocampus. Biochem Biophys Res Commun
2005;327:1036/1041.
[23] Pucadyil TJ, Chattopadhyay A. Cholesterol modulates
ligand binding and G-protein coupling to serotonin1A
receptors from bovine hippocampus. Biochim Biophys
Acta 2004;1663:188/200.
[24] Elias PM, Goerke J, Friend DS, Brown BE. Freeze-fracture
identification of sterol-digitonin complexes in cell and
liposome membranes. J Cell Biol 1978;78:577/596.
[25] Nishikawa M, Nojima S, Akiyama T, Sankawa U, Inoue K.
Interaction of digitonin and its analogs with membrane
cholesterol. J Biochem 1984;96:1231/1239.
[26] Severs NJ, Robenek H. Detection of microdomains in
biomembranes: an appraisal of recent developments in
freeze-fracture cytochemistry. Biochim Biophys Acta
1983;737:373/408.
[27] Akiyama T, Takagi S, Sankawa U, Inari S, Saitoˆ H. Saponin-
cholesterol interaction in the multibilayers of egg yolk
lecithin as studied by deuterium nuclear magnetic reso-
nance: digitonin and its analogues. Biochemistry 1980;19:
1904/1911.
[28] Dontchev V, Ichev K, Ovtscharoff W, Surchev L. Light and
electron microscopic demonstration of cholesterol distribu-
tion in membrane structures of the rat auditory cortex. Acta
Histochem 1994;96:165/174.
[29] Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner
FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ,
Klenk DC. Measurement of protein using bicinchoninic
acid. Anal Biochem 1985;150:76/85.
[30] Winter CG. Digitonin as an uncoupler of the partial
reactions of Na, K-ATPase. Ann NY Acad Sci 1974;
242:149/157.
[31] Pucadyil TJ, Chattopadhyay A. Exploring detergent insolu-
bility in bovine hippocampal membranes: a critical assess-
ment of the requirement for cholesterol. Biochim Biophys
Acta 2004;1661:9/17.
[32] McClare CWF. An accurate and convenient organic phos-
phorus assay. Anal Biochem 1971;39:527/530.
[33] Amundson DM, Zhou M. Fluorometric method for the
enzymatic determination of cholesterol. J Biochem Biophys
Methods 1999;38:43/52.
[34] Bligh EG, Dyer WJ. A rapid method of total lipid ex-
traction and purification. Can J Biochem Physiol 1959;37:
911/917.
[35] Harikumar KG, Chattopadhyay A. Differential discrimina-
tion of G-protein coupling of serotonin1A receptors from
bovine hippocampus by an agonist and an antagonist. FEBS
Lett 1999;457:389/392.
[36] Kalipatnapu S, Jafurulla MD, Chandrasekaran N, Chatto-
padhyay A. Effect of Mg2 on guanine nucleotide sensitivity
of ligand binding to serotonin1A receptors from bovine
hippocampus. Biochem Biophys Res Commun 2004;323:
372/376.
[37] Chattopadhyay A, London E. Fluorimetric determination of
critical micelle concentration avoiding interference from
detergent charge. Anal Biochem 1984;139:408/412.
[38] Lakowicz JR. Principles of fluorescence spectroscopy, 2nd
ed. New York: Kluwer-Plenum Press; 1999.
[39] Lentz BR, Moore BM, Barrow DA. Light-scattering
effects in the measurement of membrane micro-
viscosity with diphenylhexatriene. Biophys J 1979;25:489/
494.
[40] Bahouth SW, Malbon CC. Human b-adrenergic receptors:
simultaneous purification of b1- and b2-adrenergic-receptor
peptides. Biochem J 1987;248:557/566.
[41] Klein U, Gimpl G, Fahrenholz F. Alteration of the myo-
metrial plasma membrane cholesterol content with beta-
cyclodextrin modulates the binding affinity of the oxytocin
receptor. Biochemistry 1995;34:13784/13793.
[42] Chattopadhyay A. Exploring membrane organization and
dynamics by the wavelength-selective fluorescence approach.
Chem Phys Lipids 2003;122:3/17.
[43] Lentz BR. Membrane fluidity as detected by diphenylhex-
atriene probes. Chem Phys Lipids 1989;50:171/190.
[44] Prendergast FG, Haugland RP, Callahan PJ. 1-[4-(Tri-
methylamino)phenyl]-6-phenylhexa-1,3,5-triene: synthesis,
fluorescence properties, and use as a fluorescence probe of
lipid bilayers. Biochemistry 1981;20:7333/7338.
[45] Sojcic Z, Toplak H, Zuehlke R, Honegger UE, Buhlmann R,
Wiesmann UN. Cultured human skin fibroblasts modify
their plasma membrane lipid composition and fluidity
according to growth temperature suggesting homeoviscous
adaptation at hypothermic (308C) but not at hyperthermic
(408C) temperatures. Biochim Biophys Acta 1992;1104:
31/37.
248 Y. D. Paila et al.
[46] Kaiser RD, London E. Location of diphenylhexatriene
(DPH) and its derivatives within membranes: comparison
of different fluorescence quenching analyses of membrane
depth. Biochemistry 1998;37:8180/8190.
[47] Lee AG. How lipids affect the activities of integral mem-
brane proteins. Biochim Biophys Acta 2004;1666: 62/87.
[48] Jensen MØ, Mouritsen OG. Lipids do influence protein
function / the hydrophobic matching hypothesis revisited.
Biochim Biophys Acta 2004;1666:205/226.
[49] Estep TN, Mountcastle DB, Biltonen RL, Thompson TE.
Studies on the anomalous thermotropic behavior of aqueous
dispersions of dipalmitoylphosphatidylcholine-cholesterol
mixtures. Biochemistry 1978;17:1984/1989.
[50] Ruprecht JJ, Mielke T, Vogel R, Villa C, Schertler GF.
Electron crystallography reveals the structure of metarho-
dopsin. EMBO J 2004;23:3609/3620.
This paper was first published online on prEview on 28 April 2005.
Cholesterol and serotonin1A receptor function 249
